Literature DB >> 19032603

Current role of alpha-blockers in the treatment of benign prostatic hyperplasia.

Steven A Kaplan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19032603     DOI： 10.1111/j.1464-410X.2008.08086.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  4 in total

Review 1.  Advances in the design and synthesis of prazosin derivatives over the last ten years.

Authors:  Andreas Desiniotis; Natasha Kyprianou
Journal:  Expert Opin Ther Targets       Date:  2011-12-13       Impact factor: 6.902

Review 2.  [Special features of pharmacotherapy in older hypertensive subjects].

Authors:  R Kreutz
Journal:  Internist (Berl)       Date:  2009-04       Impact factor: 0.743

Review 3.  Drug Repositioning of the α1-Adrenergic Receptor Antagonist Naftopidil: A Potential New Anti-Cancer Drug?

Authors:  Romane Florent; Laurent Poulain; Monique N'Diaye
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

4.  Various treatment options for benign prostatic hyperplasia: A current update.

Authors:  Alankar Shrivastava; Vipin B Gupta
Journal:  J Midlife Health       Date:  2012-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.